The tumor suppressor role of miR-155-5p in gastric cancer

被引:39
|
作者
Li, Shiqing [1 ]
Zhang, Tao [1 ]
Zhou, Xiaoqing [1 ]
Du, Zonghan [1 ]
Chen, Fumin [1 ]
Luo, Jun [1 ]
Liu, Qingsong [2 ]
机构
[1] North Sichuan Med Coll, Clin Coll 2, Ctr Hosp Nanchong City, Dept Gastroenterol, Nanchong 637000, Sichuan, Peoples R China
[2] North Sichuan Med Coll, Affiliated Hosp, Clin Lab Dept, 63 Wenhua Rd, Nanchong 637000, Sichuan, Peoples R China
关键词
microRNA-155-5p; proliferation; apoptosis; gastric cancer; INHIBITS HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; PROGNOSIS; PROMOTES; METASTASIS; GROWTH; EXPRESSION; INVASION;
D O I
10.3892/ol.2018.8932
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer (GC) is the fifth most common type of malignant tumor worldwide and the most common cause of cancer-associated mortality in China. Recent studies revealed that microRNAs (miRNAs) function in the pathogenesis of GC, and that miR-155-5p expression is downregulated in GC tissues. However, the function of miR-155-5p has not been fully identified. In the present study, it was demonstrated that overexpression of miR-155-5p inhibited GC-cell proliferation and promoted apoptosis, while downregulation of miR-155-5p promoted GC-cell proliferation and decreased the cisplatin sensitivity of GC cells. Mitogen-activated protein kinase kinase kinase 10 was demonstrated to be a potential target gene of miR-155-5p. In conclusion, an antitumor role of miR-155-5p in gastric cancer was suggested.
引用
收藏
页码:2709 / 2714
页数:6
相关论文
共 50 条
  • [31] Expression and diagnostic value of miR-142-5p and miR-155-5p in the serum of children with allergic rhinitis
    Liu, Huihui
    Ma, Guiqin
    Xing, Enhong
    Xu, Meihua
    Song, Xianyong
    Zhang, Yuli
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2023, 165
  • [32] Exosomal miR-155-5p promotes proliferation and migration of gastric cancer cells by inhibiting TP53INP1 expression
    Shi, Shuai-Shuai
    Zhang, Hui-Peng
    Yang, Chang-Qing
    Li, Li-Na
    Shen, Yu
    Zhang, Yi-Qiang
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (06)
  • [33] Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relation
    Abdelneam, Ahmed Ibrahim
    Al-Dhubaibi, Mohammed Saleh
    Bahaj, Saleh Salem
    Mohammed, Ghada Farouk
    Atef, Lina Mohammed
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [34] XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p
    Lin, Xiu-qing
    Huang, Zhi-ming
    Chen, Xin
    Wu, Fang
    Wu, Wei
    YONSEI MEDICAL JOURNAL, 2018, 59 (07) : 816 - 826
  • [35] miR-155-5p expression is associated with response to neoadjuvant paclitaxel treatment of locally advanced breast cancer
    Straume, Anne Hege
    Birkeland, Einar
    Knappskog, Stian
    Lemning, Per Eystein
    CANCER RESEARCH, 2015, 75
  • [36] miR-155-5p and miR-1246 as promising biomarkers in oral squamous cell carcinomas
    Ramamoorthy, Maheswari
    Guru, Sameer A.
    Koner, Bhidhan C.
    Kumar, Priya
    Urs, Aadithya B.
    ANNALS OF ONCOLOGY, 2022, 33 : S498 - S499
  • [37] Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer
    Zhang, Xiao-Fei
    Tu, Rongfu
    Li, Keke
    Ye, Pengxiang
    Cui, Xiaofeng
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (10) : 3391 - 3400
  • [38] Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease
    Divi, Srikanth N.
    Markova, Dessislava Z.
    Fang, Taolin
    Guzek, Ryan
    Kurd, Mark F.
    Rihn, Jeffrey A.
    Hilibrand, Alan S.
    Anderson, David Greg
    Vaccaro, Alexander R.
    Schroeder, Gregory D.
    Kepler, Christopher K.
    SPINE, 2020, 45 (09) : E499 - E507
  • [39] lncRNA NORAD promotes the progression of osteosarcoma via targeting of miR-155-5p
    Wang, Ye
    Zhou, Bin
    Yan, Liping
    Wu, Jianhui
    Xing, Zhijie
    Zhang, Shaochun
    Xiang, Fusheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [40] miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells
    Wang, Qian
    Li, Ce
    Zhu, Zhitu
    Teng, Yuee
    Che, Xiaofang
    Wang, Yan
    Ma, Yanju
    Wang, Yiding
    Zheng, Huachuan
    Liu, Yunpeng
    Qu, Xiujuan
    ANTI-CANCER DRUGS, 2016, 27 (01) : 9 - 16